HIGHLIGHTS
- who: Matteo Ponzo et al. from the IMRB University of Paris-Est Creteil (UPEC), IMRB, Cru00e9teil, France have published the research: Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression, in the Journal: Cancers 2022, 14, x FOR PEER REVIEW of /2022/
- what: The authors aimed to characterize the immune microenvironment of the orthotopic mPDAC tumours. The authors aimed to assess whether N6L treatment could affect immune cell infiltration into the tumours. Treg content and CD8/Treg ratio were not modified in tumour lymph nodes or spleen of N6L-treated Cancers 2022, 14, x FOR PEER REVIEW . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.